• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

From Genetics to Soybeans: What are the Risk Factors for Uterine Fibroids?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • May occur in up to 70% of women by menopause and will be clinically apparent in 25% of women of reproductive age
    • 25% of women will require treatment
  • Stewart et al. (BJOG, 2017) is the first systematic review of epidemiology to assess the contribution of risk factors associated with fibroids

METHODS:

  • Systematic search of papers related to risk factors, without specifically selecting for symptomatic or asymptomatic fibroids (1995-2015)
  • Analyses were conducted on pooled data from relevant publications and registries
  • Data on UF incidence, prevalence and associated risk factors were extracted from 60 publications

RESULTS:

  • A wide range of both UF incidence (217-3,745 cases/100,000 women-years) and prevalence (4.5%-68.6%) were reported
    • No consistent associations between prevalence and country/region, study methodology or population were seen across the studies
  • Black race compared to white race was the only factor consistently found to increase UF risk (2-3 fold increase)
  • Owing to the large number of risk factors, researchers focused on risk factors for which the magnitude of the effect was approximately the same as or greater than the effect of race (i.e. 95% CI ≥1.5 for a risk factor or ≤0.67 for a protective factor)
    • Using this criterion, 11 other factors were identified
  • Other factors that increased UF risk include
    • Age (up to 10-fold increase up until age 60)
    • Premenopausal state (3- to 5-fold)
    • Hypertension (SBP ≥ 140 mmHg; DBP ≥90 mmHg or current use of antihypertensive medication) had an almost fivefold increased risk)
    • Family history (3-fold)
    • Time since last birth (2-3 fold if gave birth > 5 years ago)
    • Food additives (processed, sweetened or preserved foods) and soybean milk consumption had a 2.5-fold greater risk
  • UF risk was decreased using
    • Oral contraceptives (70% lower risk who currently use vs never use)
    • Injectable contraceptive depot medroxyprogesterone acetate (less than ½ as likely)
    • Smoking in women with low BMI
    • Parity (risk 1/5 of nulliparous if ≥ 3 deliveries)

CONCLUSION:

  • This study identified 12 risk factors for fibroids, confirming race and age as primary risk factors
  • This study did not address symptomatic vs non-symptomatic fibroids

Learn More – Primary Sources:

Epidemiology of uterine fibroids: a systematic review

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Practical info for your gynecology practice
Hormonal Contraception Benefits – Beyond Pregnancy Prevention
Uterine Artery Embolization or Hysterectomy for Fibroids?
High-Intensity Focused Ultrasound – An Option for Fibroids
Uterine Artery Embolization or Focused Ultrasound for Uterine Fibroids?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site